Julie Lajeunesse

“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises

Kaitlyn Jaffe, Scott Harrison, E. Oviedo-Joekes, 2023, Harm Reduction Journal.

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, The International journal on drug policy.

Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, BMC Health Services Research.

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, The International journal on drug policy.

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, International Journal of Drug Policy.

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, Substance Abuse Treatment, Prevention, and Policy.

Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling task.

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2024, Addiction.